Strikingly, FASN H-scores were significantly higher in individuals with CRC classified as ATF6-high compared to those classified as ATF6-low (Fig. 2i), identifying a positive correlation between ATF6 and FASN expression in CRC human tissue. This evidence concerns the gene FASN and colorectal carcinoma.